Abstract

Objective To probe into X-ray, CT and MRI manifestations of bone turnover in skeletal fluorosis and diagnostic values of different examination technologies. Methods Comparisons and analyses were made on the imaging manifestations of bone turnover in 28 reported cases with skeletal fluorosis. Results All 28 cases had dental fluorosis of different degrees. The chief symptoms included arthralgia and aching muscle pains in four limbs; 13 cases had joint motion limitation and dysfunction, 28 cases had spinal pain and 26 cases (92.85%) had pain in the lumbar region and legs. As to the imaging manifestations, 17 cases mainly had hyperostosis and 11 cases mainly had osteopenia; 5 had fuzzy bone trabecula, 9 loosening of cortical bone and 19 sclerosis of cancellous bone; 7 cases were complicated by biconcave deformity of vertebral body and 6 cases by pelvic deformity; 4 cases manifested the formation of false fracture line, and 7 cases manifested disorder of bone growth and development. Conclusions: MRI may distinctly display early changes of bone turnover in patients with skeletal fluorosis with high diagnostic sensitivity.

• Related Studies :

  • An epidemiological study of skeletal fluorosis in some villages of Chandrapur District, Maharashtra, India

    Fluorosis is an important public health problem in certain parts of India. Chandrapur is one of the fluorosis endemic district of Maharashtra. An investigation was undertaken in three villages of study area to assess the clinical symptoms of skeletal fluorosis and in turn to find out the severity of the

  • Alert on long-term lumbago and skelalgia not responsive to anti-rheumatic pharmacotherapy

    In our work we have often dealt with patients who were diagnosed with “rheumatic or rheumatoid arthritis” in rural basic medical units or certain hospitals. A minority of those patients did have rheumatoid arthritis, but most of them did not improve with anti-rheumatic pharmacotherapy for multiple years; instead, their conditions

  • Dorsal spondylolisthesis secondary to chronic fluoride intoxication: one case report

    Fluorosis is a disease caused by an excess of fluoride in the water, it is endemic in many parts of India,Afghanistan; Irak, Iran and North Africa. Fluoride is retained in the bones and induces hardening of all the bones, including the spine, hypertrophy of the joints and bones is seen,

  • [Ossification of ligament and tendon attached around the elbow joint in diagnosis of skeletal fluorosis].

    Objective: To probe into the significance of osteosis of the junctions of ligaments and tendons around elbow joints for the diagnosis of skeletal fluorosis. Methods: Analyses were conducted on X-ray signs of elbow joints in 23 cases with skeletal fluorosis and fluoridated elbow joints identified in March 2011 in an

  • Enduring fluoride health hazard for the Vesuvius area population: the case of AD 79 Herculaneum

    BACKGROUND:  The study of ancient skeletal pathologies can be adopted as a key tool in assessing and tracing several diseases from past to present times. Skeletal fluorosis, a chronic metabolic bone and joint disease causing excessive ossification and joint ankylosis, has been only rarely considered in differential diagnoses of palaeopathological

• Related FAN Content :

  • "Pre-Skeletal" Fluorosis

    As demonstrated by the studies below, skeletal fluorosis may produce adverse symptoms, including arthritic pains, clinical osteoarthritis, gastrointestinal disturbances, and bone fragility, before the classic bone change of fluorosis (i.e., osteosclerosis in the spine and pelvis) is detectable by x-ray. Relying on x-rays, therefore, to diagnosis skeletal fluorosis will invariably fail to protect those individuals who are suffering from the pre-skeletal phase of the disease. Moreover, some individuals with clinical skeletal fluorosis will not develop an increase in bone density, let alone osteosclerosis, of the spine. Thus, relying on unusual increases in spinal bone density will under-detect the rate of skeletal fluoride poisoning in a population.

  • Fluoride & Osteoarthritis

    While the osteoarthritic effects that occurred from fluoride exposure were once considered to be limited to those with skeletal fluorosis, recent research shows that fluoride can cause osteoarthritis in the absence of traditionally defined fluorosis. Conventional methods used for detecting skeletal fluorosis, therefore, will fail to detect the full range of people suffering from fluoride-induced osteoarthritis.

  • Skeletal Fluorosis: The Misdiagnosis Problem

    It is a virtual certainty that there are individuals in the general population unknowingly suffering from some form of skeletal fluorosis as a result of a doctor's failure to consider fluoride as a cause of their symptoms. Proof that this is the case can be found in the following case reports of skeletal fluorosis written by doctors in the U.S. and other western countries. As can be seen, a consistent feature of these reports is that fluorosis patients--even those with crippling skeletal fluorosis--are misdiagnosed for years by multiple teams of doctors who routinely fail to consider fluoride as a possible cause of their disease.

  • Estimated "Threshold" Doses for Skeletal Fluorosis

    For over 40 years health authorities stated that in order to develop crippling skeletal fluorosis, one would need to ingest between 20 and 80 mg of fluoride per day for at least 10 or 20 years. This belief, however, which played an instrumental role in shaping current fluoride policies, is now acknowledged by the National Academy of Sciences (NAS) and other US health authorities to be incorrect.

  • Mayo Clinic: Fluoridation & Bone Disease in Renal Patients

    The available evidence suggests that some patients wtih long-term renal failure are being affected by drinking water with as little as 2 ppm fluoride. The finding of adverse effects in patients drinking water with 2 ppm of fluoride suggests that a few similar cases may be found in patients imbibing 1 ppm, especially if large volumes are consumed, or in heavy tea drinkers. The finding of adverse effects in patients drinking water with 2 ppm of fluoride suggests that a few similar cases may be found in patients imbibing 1 ppm, especially if large volumes are consumed, or in heavy tea drinkers and if fluoride is indeed the cause. It would seem prudent, therefore, to monitor the fluoride intake of patients with renal failure living in high fluoride areas.